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Objectives
SELPHI (HIV Self-Testing Public Health Intervention) is the largest randomized controlled trial
(RCT) of HIV self-testing (HIVST) in a high-income setting to date, and has recruited 10 000 men
who have sex with men (cis- and transgender) and transgender women who have sex with men.
This qualitative substudy aimed to explore how those utilizing self-tests experience HIVST and the
implications for further intervention development and scale-up. This is the first qualitative study in
Europe investigating experiences of HIVST among intervention users, and the first globally
examining the experience of using blood-based HIVST.
Methods
Thirty-seven cisgender MSM SELPHI participants from across England and Wales were purposively
recruited to the substudy, in which semi-structured interviews were used to explore testing history,
HIVST experiences and intervention preferences. Interviews were audio-recorded, transcribed and
analysed through a framework analysis.
Results
Men accessed the intervention because HIVST reduced barriers related to convenience, stigma and
privacy concerns. Emotional responses had direct links to acceptability. Supportive intervention
components increased engagement with testing and addressed supportive concerns. HIVST
facilitated more frequent testing, with the potential to reduce sexually transmitted infection (STI)
screening frequency. Substudy participants with an HIV-positive result (n = 2) linked to care
promptly and reported very high acceptability. Minor adverse outcomes (n = 2; relationship
discord and fainting) did not reduce acceptability. Ease of use difficulties were with the lancet and
the test processing stage.
Conclusions
Intervention components shaped acceptability, particularly in relation to overcoming a perceived
lack of support. The intervention was broadly acceptable and usable; participants expressed an
unexpected degree of enthusiasm for HIVST, including those with HIV-positive results and
individuals with minor adverse outcomes.
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Introduction
Reducing the prevalence of undiagnosed HIV infection is a
key public health goal [1,2] enshrined in the Joint United
Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 tar-
gets; 90% of people with HIV infection diagnosed, 90% of
people diagnosed on treatment and 90% of people on treat-
ment achieving virological suppression [1]. The UK has
been successful in this regard, with London the first city
globally to achieve 95-95-95 [3]. While the HIV incidence
in England is falling in gay men, expanding testing
remains a priority, with prompt diagnoses and linkage into
clinical services for those testing positive [4,5]. Despite the
British HIV Association recommending annual testing for
men who have sex with men (MSM) (or more frequently if
at ongoing risk) [6], up to 25% of gay men and bisexual
men have never tested and approximately half have not
tested in line with these guidelines [7,8].
HIV self-testing (HIVST) is an approach whereby an
individual uses a rapid diagnostic test and interprets their
own result. HIVST has the potential to increase testing by
providing convenience, privacy and accessibility [9,10].
The World Health Organization (WHO) recommends
HIVST as a testing option [11].
HIV self-testing was legalized in the UK in 2014, with
the first test coming to market in 2015 [10,12,13]. Wide-
spread free public provision of HIVST has yet to occur in
the UK. Pilot and demonstration projects have delivered a
limited number of free tests, mainly to MSM and black
African people [14–16].
Acceptability studies have focused on potential users of
HIVST, with limited numbers of actual self-testers
included in these formative studies [10,13,17]. Evidence
of actual user experience from the UK and from Europe
more broadly is limited [18].
SELPHI (HIV Self-Testing Public Health Intervention) is
the largest randomized controlled trial (RCT) of HIVST in
a high-income setting to date. SELPHI has recruited
10 000 MSM (both cisgender and transgender) and trans-
gender women who have anal sex with men. SELPHI has
two randomizations and two versions of the primary in-
tervention. In randomization A, the 10 000 participants
were allocated at a ratio of 60:40 to a single HIVST (in-
tervention A) at baseline versus standard of care (SoC)
(signposting to free testing services). In randomization B
(which occurred 3 months post enrolment), eligible par-
ticipants who had been allocated to HIVST in randomiza-
tion A, remained HIV-negative and reported condomless
anal intercourse (CAI) in the preceding 3 months were
randomized 50:50 to the offer of 3-monthly repeat HIVST
with test reminders (intervention B) versus SoC. SELPHI
has recruited from geolocation hook-up applications
(apps) and from social media. All RCT data collection was
online, and blood-based test kits (BioSure (UK) Ltd, Naze-
ing, UK) were delivered by post directly from the test
manufacturer. To use the BiosureTM kit, users draw a
blood sample using a capillary lancet, collect the sample
in a test stick, push the test stick into a buffer pot, then
wait 15 min before interpreting the result using included
instructions. For the SELPHI protocol, see Gabriel et al.
2018 [19].
The interventions included multiple components which
worked together to support uptake of HIVST, continued
engagement with testing more broadly and linkage to
care if positive (see Fig. 1). Intervention A began with
targeted recruitment through adverts on apps and social
media designed to increase motivation to test and reduce
perceived capability barriers; then a baseline risk assess-
ment (enrolment survey), which collected demographic
and behavioural data prior to randomization A in which
participants were allocated to being offered an HIVST kit
or not. The HIVST kit was then delivered by post
directly by the manufacturer. Following kit delivery a 2-
week follow-up survey was sent via email which asked
for confirmation of receipt and use of the kit, the result
and provided linkage to care information for those with
positive results. All those randomized to receive HIVST
in intervention A were entered into randomization B (pro-
vided they met eligibility criteria outlined above) and
were randomized to SoC or to intervention B, in
which HIVST kits were offered 3-monthly for up to
2 years. They received a test reminder with an embedded
risk assessment which was delivered every 3 months, with
provision of a further test if desired with an additional
follow-up survey 2 weeks afterwards (see Fig. 2). Both
interventions were modelled on what would probably be
provided in routine online provision of free kits
[14,15,20].
This SELPHI substudy addresses critical questions sur-
rounding intervention acceptability and kit usability. The
substudy aimed to explore the experience of utilizing HIV
self-tests and the implications for further intervention
development and scale-up. The specific objectives were to
understand motivations for accessing HIVST; to explore
intervention acceptability; and to characterize experi-
ences of kit use.
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Methods: This qualitative substudy involved 37 semi-
structured interviews with cisgender MSM within the
SELPHI RCT. The first 10 interviews took place in May
2017 during the pilot phase, with the remaining 27
conducted during the main trial between January and
October 2018.
Interviews were conducted remotely (n = 17) or face to
face (n = 20) depending on location, with a geographical
spread of participants across England and Wales. We
recruited 25 participants who received intervention A
only, 10 who received intervention B and two who
reported a positive result (both from intervention A). Pur-
posive sampling ensured diversity in HIV testing experi-
ence, age, highest educational qualification (HEQ) and
ethnicity. Potential participants who consented to in-
depth interviews were approached by the lead author
who provided details about the study and scheduled
interviews. The face-to-face interviews were conducted in
Cardiff and Newcastle to increase the diversity of experi-
ence of levels of gay community and social opportunity,
as well as smaller scale HIV/STI service infrastructure.
Participants provided written or verbal recorded consent
and were compensated £30 for their involvement. Only
cisgender MSM were included, as a study exclusively
with transgender participants is ongoing [21,22].
The topic guide covered testing history, engagement
with SELPHI, experience of the interventions and prefer-
ences for future HIVST interventions. It was piloted with
two participants, refined, and used for a further eight
Fig. 1 The SELPHI (Self-Testing Public Health Intervention) interven-
tion A.
Fig. 2 The SELPHI (Self-Testing Public Health Intervention) interven-
tion B.
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interviews. Following this, additional questions were added
to explore intervention acceptability in greater depth,
including a demonstration of the kit and a revisiting of the
supportive components of the interventions.
Ethical approval was granted by University College Lon-
don (UCL) (ref: 11945) and the London School of Hygiene
and Tropical Medicine (LSHTM) (ref: 9233/001).
Interviews, all conducted by the lead author, were
audio-recorded and transcribed verbatim. Data analysis
followed a Framework approach [23,24]. Our framework
drew from theorized key components of intervention
acceptability from formative work, the wider literature and
systematic reviews [10,17,25]. This framework was piloted,
refined and applied to all transcripts by the lead author.
Results
The sample of 37 men was diverse with regard to age,
education, previous HIV testing history, and number
of CAI partners (Table 1). Thirty-five reported receiving a
negative self-test result and two had received a positive
result from their self-test. Here we outline two broad
areas: experience of the HIVST intervention (focussed on
acceptability), and experience of using the kit (usability).
Intervention experiences
This section relates to participant experiences of the over-
all intervention. First, we consider the appeal of the inter-
ventions, including initial motivations to access HIVST.
Secondly, we discuss the acceptability of the psychosocial
components embedded in the surveys, and then we dis-
cuss support structures, and finally outcomes.
Appeal, attraction and engagement
Study adverts were felt to be relevant, engaging and
straightforward. These were praised for using simple lan-
guage and for highlighting that the intervention was free,
that the kit was simple to use and that the testing process
was quick. For others, the adverts simply highlighted an
attractive, more convenient testing opportunity. Those
who did not report significant appeal based on the advert
usually reported that the advert served as a prompt when
they were considering testing anyway.
For those testing in response to a sexual risk event,
HIVST provided a new way to access testing, overcoming
personal barriers related to stigma and privacy concerns.
This was most pronounced for those who had not previ-
ously tested, or those disengaged from testing services.
Yes, it was something new, it was giving me the
ability to do it in private so I didn’t have to go
somewhere I might bump into somebody who
knows me. You know clinics, there’s a stigma there.
And yes I think it was just the ease of it, the fact
that I could do it at home in private on my own
but I would get an answer, a yes or a no. (39 year-
old gay man, not previously tested)
Neither of those who received a positive result had pre-
viously tested for HIV. They cited barriers related to
stigma, geography and inconvenient clinic hours, but felt
these issues were resolved by the opportunity to self-test.
For men testing for reassurance or as part of routine
practice, HIVST offered an increase in convenience and a
reduction in opportunity cost, overcoming barriers related
to inconvenient clinical opening times, poor service qual-
ity and distance to services.
An important additional motivation to seek HIVST was
curiosity about a new technology. This was often a pri-
mary motivator, particularly common among those who
had recently tested via another method, but was also
Table 1 Participant demographic characteristics
Demographic characteristic Number of participants
Age
16–25 years 11
26–40 years 16
≥ 41 years 10
Ethnicity
White 29
Black 3
Asian 2
Other/ mixed 3
Sexual orientation
Gay 24
Bisexual 5
Don’t use a term 1
Undisclosed 7
Recency of HIV testing
Never tested 7
≥ 12 months 17
< 12 months 13
Highest educational qualification (HEQ)
Low* 7
Medium† 11
High‡ 19
Number of CAI partners in preceding 3 months
0 12
1 14
2–3 7
4–10 4
> 10 0
HIVST outcome
Positive 2
Negative 35
Intervention
A 27
B 10
CAI, condomless anal intercourse; HIVST, HIV self-testing.
*GCSEs and below.
†A-levels or equivalent; higher education below degree level.
‡Degree or higher.
© 2019 The Authors.
HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association
HIV Medicine (2019)
4 TC Witzel et al.
reported as a secondary motivator for MSM who had not
previously tested for HIV.
The appeal of HIVST was mediated by emotional responses.
Self-testing was perceived as generating either more or less
anxiety, relative to other testing methods, primarily based on
testing history and motivation for testing. For some infre-
quent testers with concerns about health care professionals,
the personal control provided by HIVST decreased anxiety by
placing them at the centre of their decision-making.
It [getting the result] felt the same as the other times with
my doctor. . . my doctor telling me, except a lot more
comfortable [. . .] because I then was the one. . . I’m now
in control. And I suppose the same would’ve been if it
had have been a positive result. I would have been the
one in control of going to my doctor and saying, ‘I’ve
gone ahead and done this. It’s come back like this and I
need you to investigate’. (49 year-old man, undisclosed
sexual orientation, tested in preceding 5 years)
Those with more routine experience of testing tended
to describe self-testing as helpful for reducing anxiety by
facilitating testing in a comfortable setting. For some
with less HIV testing experience and men who had recent
risk, HIVST amplified emotional responses because of the
solitary nature of its use.
Risk, reflection and recognition
The supportive elements of the interventions (the beha-
vioural questions in the survey, 2-week follow-up and
testing reminders for those receiving multiple HIVST
kits through intervention B) were generally praised for
increasing engagement with testing. The follow-up after
receiving a test provided a sense of connection to the
trial, and an expectation that supportive action would be
taken if a result was positive.
For participants receiving the offer of repeat HIVST, the
testing reminders and risk assessments embedded in sur-
veys provided an opportunity for reflection about recent
sexual activity. This reflective experience was described
either in neutral or positive terms; none felt it was not
worthwhile or that it created significant discomfort.
Just made me think a bit harder of the past three
months, what I’d been doing. It didn’t make me
feel anything like I shouldn’t be asked this [. . .] it
just made me think about all the movement I had
in the last three months. (27-year-old gay man,
tested in preceding 6 months)
Care, support and follow-up
This theme relates to the supportive structures within
the intervention which facilitated uptake, including
accompanying information describing what to do in the
event of a positive result and the 2-week follow-up survey.
The support structures were largely considered appro-
priate and in line with expectations. For those with con-
cerns about the dislocation of testing from care, these
structures helped to increase intervention acceptability.
I liked the fact that when I opened it, the first thing
was the card that fell out and it was, kind of, like,
one side was, ‘If you’re negative, great, continue to
test, continue to use condoms, continue to have
safe sex,’ and then the other side was, ‘If you’re
positive don’t worry, we can help you,’ etc. So that
was quite comforting. (35-year-old gay man, tested
more than 12 months ago)
Rather than source support through the intervention
structures, most individuals with emotional support
needs (regarding both positive and negative results)
looked to their social networks, drawing on partners,
family and friends. Both men who reported a positive
result first spoke to a family member or friend who
supported them in seeking confirmatory testing at a
clinic.
Impacts, outcomes and expectations
Outcomes following testing varied, especially in relation
to HIV testing history. Changes in testing behaviour
appeared most pronounced among those with less testing
experience. For these men, the interventions dramatically
increased accessibility, facilitating testing when they
would not have tested otherwise. This group also
described reductions in barriers to other testing services,
partly through an easing of anxiety facilitated by famil-
iarity with testing and partly through increased engage-
ment with services in general.
For many, HIVST increased testing frequency by facili-
tating testing between clinic visits. This was most pro-
nounced amongst those receiving intervention B, but was
described by individuals who received only a single
test from intervention A.
Those who did not have well-established testing pat-
terns felt that they were likely to entirely replace clinic
HIV tests with self-tests as their needs were better met
through this means of testing, thus potentially reducing
STI testing frequency.
Well, [my behaviour since joining SELPHI] has
already changed in a sense that I’m now getting
tested every three months, [. . .] even if I don’t
receive one through you guys, I can buy it. (27-
year-old bisexual man, tested in preceding
6 months)
© 2019 The Authors.
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Both men who received a positive result linked to care
within 24 h. One had a very low CD4 count indicative of a
long-established infection. Receiving positive results
through self-testing did not diminish intervention accept-
ability, with both stating self-testing had ‘saved their life.’
It’s [HIVST] stopped me transmitting it to other people
and saved my life. So yes, even though I got my bad
news, it’s been a very positive experience. I would
recommend anybody do it, anybody who has got con-
cerns, like I had, about going to clinics and stuff like
that, get yourself a self-test. (49-year-old gay man,
not previously tested, positive result)
Two participants reported negative outcomes related
to the interventions. An individual who was receiving
repeat self-tests shared a test with his partner whose
family found it, prompting relationship discord. Another
participant fainted on using the lancet to draw blood.
These experiences did not diminish acceptability; both
men stated they would be happy to use self-tests in
the future.
Test kit usability
This section relates to men’s experiences using the actual
kit. First, we explore capability concerns and test errors,
then the emotional impact of using the kit. Finally, we
describe participant beliefs regarding sensitivity, speci-
ficity and accuracy.
Capability, cognition and ease of use
For individuals engaging with HIVST, questions
around their own capacity to perform the test were
commonplace. The majority used the written instruc-
tions provided, with a minority accessing online
videos.
While most found using the test straightforward, issues
with the lancet were common. A further area of concern
for many was pressing the test stick into the pot contain-
ing the buffer solution. The information provided was felt
not to be sufficiently clear, exacerbating confusion about
how far to push the test stick in, and concern about
breaking it.
This was the confusing part because this is a square
and this is round. So I wasn’t sure if this was sup-
posed to go there. And looking at this just at first,
you are not sure because, okay, this is round, this
is a square. And it doesn’t fit instinctively there. So
this was where I was confused. This was the part
that give me a lot of grief. (40-year-old gay man,
tested in preceding 12 months)
One individual accidentally released the lancet early,
but was able to draw blood by using the needle to prick
himself. Two individuals were unable to complete their
first test, both because of confusion with how to insert
the test stick into the buffer pot. Both sourced a replace-
ment kit from the study team.
Participants universally felt that, with increased experi-
ence, these issues would not recur. This was also con-
firmed by participants receiving repeat HIVST kits who
reported that increased use enhanced confidence and
competence.
Anxiety, relief and emotional engagement
The 15-min interval between completing testing steps
and reading the result was nearly universally described as
a period of heightened anxiety. This feature of the test
provoked emotional responses beyond that experienced
waiting for results through other testing opportunities
(e.g. at sexual health clinics) for nearly all participants,
even those who felt HIVST reduced anxiety overall.
The level of anxiety experienced varied according to
testing history and the self-assessment of risk: those with
more testing experience who were testing out of routine
tended to be less anxious. For individuals testing follow-
ing a risk event and for those without established routi-
nes (even if low risk), this wait generated profound
feelings of vulnerability.
When I start doing the test, no [I didn’t think it
could be positive]. When I’d done the test and then
I’m waiting I’m convinced I’ve got everything from
Ebola to SARS to HIV. So then it’s not until I actu-
ally get the result that I’m confident again. But
there’s always just that creeping panic that you
could have something, because you don’t know.
(25-year-old gay man, tested in preceding
12 months)
Unsurprisingly, individuals with positive results
described the experience as deeply upsetting, but also
described the accompanying support information as being
appropriate for their needs. Their emotional responses did
not diminish intervention acceptability as both expressed
great enthusiasm for HIVST.
Sensitivity, specificity and beliefs about accuracy
Participants with more testing experience sometimes had
questions about HIVST accuracy. This concern was typi-
cally about completing the test as well as questions
related to reliability of the technology. These concerns
were usually dispelled through the support information or
upon receiving a negative test result.
© 2019 The Authors.
HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association
HIV Medicine (2019)
6 TC Witzel et al.
While the vast majority of those with negative results
trusted that the test outcome was valid (with the excep-
tion of one who had made significant test errors), both
men with positive results had significant doubts as to
whether the result was correct. This was a primary moti-
vator to seek confirmatory testing.
Honestly I was 50/50 on it [accuracy] because I
don’t know, I just thought shit, what if I have
[HIV] [. . .] it’s not 100% accurate and then I didn’t
know. I wanted to get a proper full-on test. I know
this is a proper test as well, but I just wanted a
doctor doing it. (21-year-old gay man, not previ-
ously tested, positive result)
Discussion
This study explored key dimensions of HIV self-test inter-
vention acceptability and kit usability among 37 cisgender
MSM drawn from a large HIVST RCT. Self-testing had dif-
ferent appeal depending on previous testing history and
their motivations for accessing testing. In nearly all cases,
HIVST reduced barriers to testing, which related to either
stigma and privacy issues, or convenience and opportunity
cost. Supportive intervention components increased testing
engagement more broadly. The intervention support struc-
tures were adequate, although most support was drawn
from social networks. The kit itself was well regarded, with
few significant errors. Concerns regarding kit reliability
typically resolved following a negative result, but persisted
for those who tested positive. Both participants with posi-
tive results linked to care within 24 h.
Those without established testing routines and individu-
als with recent risk concerns found HIVST to induce anxi-
ety, especially the 15-min interval between using the test
and reading the result. This feature produced profound
feelings of vulnerability, beyond what would be experi-
enced while testing through a different method. For others,
HIVST reduced anxiety relative to other models by putting
them in control of the testing process. This underlines the
central role of anxiety in HIV testing; anxiety may produce
a key testing barrier for many regardless of their risk and
testing history, although perhaps at different stages in the
process depending on the testing technology and setting.
These findings underline the importance of intervention
design in service delivery and the value of formative work
with intended beneficiaries. Each component of both inter-
ventions (the advertisements, risk assessments, support
components and the kit itself) had a specific relationship
with acceptability, in most cases overcoming documented
HIVST barriers such as lack of support [10,13,17,25].
This qualitative study demonstrates the potential for
HIVST to increase testing frequency for frequent and
infrequent testers, in line with existing RCT evidence
[26,27]. Infrequent testers may access sexual health clin-
ics less often, however, potentially reducing STI testing in
this group, also consistent with existing evidence from
the USA but contradicting an Australian study [26,27].
Offering bacterial STI self-sampling alongside HIVST may
ameliorate this. The final RCT results will provide crucial
evidence regarding this outcome.
Given that those new to testing frequently accessed the
intervention in response to risk, it is especially important
that clear information regarding test window periods is
provided for those with less testing knowledge. The signif-
icant distrust of their results reported by both participants
with a positive result underlines the importance of clear,
supportive information providing an accessible pathway
into clinical care no matter the geographical location.
Finally, minor adverse outcomes (fainting; relationship
discord) were reported by two participants. Further
research into potentially harmful outcomes is required to
develop strategies to ameliorate these. This is particularly
important given concerns about the potential for harm
arising from HIVST despite the lack of evidence to date
[10,12,28–30].
Strengths and limitations
To our knowledge, this is the first European study that
has examined self-testing intervention acceptability solely
among actual HIVST users and will be useful for those
working with similar groups in similar health care set-
tings. Nevertheless, some limitations are noted.
The majority of our participants reported negative
results. Thus, the data pertaining to those with positive
results cannot be considered representative of the experi-
ences of others.
All participants chose to participate in an RCT that
delivered an HIVST to an address (residential or other-
wise) and that collected substantial amounts of personal
data, and all of them consented to being interviewed.
This sample, therefore, potentially does not include those
with the greatest concerns surrounding disclosure of sen-
sitive information about themselves, a group hypothe-
sized to have a heightened need for HIVST [10,25].
Conclusions
This study explored how those using self-tests experience
HIV self-testing and implications for intervention devel-
opment and scale-up. Previous testing experience was
© 2019 The Authors.
HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association
HIV Medicine (2019)
HIVST intervention experiences and usability 7
key in shaping intervention acceptability and test kit
usability. Men were motivated to access the intervention
because HIVST reduced specific HIV testing barriers
related to convenience, stigma and privacy concerns. The
intervention was acceptable, with participants expressing
an unexpected degree of enthusiasm for self-testing,
including those with positive results and individuals who
experienced adverse events.
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